Latest filing published 21 May 2025 for Theravance Biopharma, Inc..
Insider track record
No signal scores available.
Jeremy T. Grant: trading record in brief
Jeremy T. Grant discloses dealings in Theravance Biopharma, Inc. to SEC (Form 4). Over a trading history stretching from 21 December 2023 to 19 May 2025, the count stands at 4 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 21 May 2025, reports a share grant in Theravance Biopharma, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jeremy T. Grant
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,649 shares0Ordinary SharesSEC:0001415889-25-014005:0
- 10,537 shares0Ordinary SharesSEC:0001415889-24-012911:0
- 2,942 shares0Ordinary SharesSEC:0001415889-23-016943:1
- 8,826 shares0Ordinary SharesSEC:0001415889-23-016943:0
4 of 4 declarations
